Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
23andMe Holding ( (ME) ) has issued an update.
On March 23, 2025, 23andMe Holding Co. filed for Chapter 11 bankruptcy protection, seeking relief under the United States Bankruptcy Code. The company has entered into a $35 million loan agreement with JMB Capital Partners Lending, LLC to support its operations during the bankruptcy process. Additionally, Anne Wojcicki resigned as CEO, with Joseph Selsavage appointed as interim CEO. The company is also pursuing a structured sale of its assets and has settled claims related to a previous cyber incident for $37.5 million.
More about 23andMe Holding
23andMe Holding Co. operates in the biotechnology industry, primarily offering genetic testing services to consumers. The company focuses on providing personalized health insights and ancestry information through DNA analysis.
YTD Price Performance: -49.58%
Average Trading Volume: 291,784
Technical Sentiment Signal: Buy
Current Market Cap: $48.02M
See more insights into ME stock on TipRanks’ Stock Analysis page.